Dataset Information


Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?

ABSTRACT: UNLABELLED:Photoimmunotherapy is a highly cell-selective cancer therapy based on an armed antibody conjugate with a phthalocyanine-based photosensitizer, IR700. Photoimmunotherapy induces rapid and highly specific necrosis in targeted cancer cells after exposure to near-infrared (NIR) light. Cells not expressing the antigen are not affected. To date, photoimmunotherapy has been demonstrated only with full antibody-IR700 conjugates. In this study, small and bivalent antibody fragments, including anti-prostate-specific membrane antigen (PSMA) diabody (Db) and minibody (Mb), were compared with intact IgG for their effectiveness as photoimmunotherapy agents. METHODS:Radioiodinated antibody and antibody fragments with (125)I were used to determine the timing of maximum binding of each anti-PSMA antibody fragment on the cell surface in vivo in mice bearing either PSMA-positive or -negative PC3 tumors. Then therapeutic efficacy of photoimmunotherapy was examined by exposing mice to NIR light at 2 time points based on the time of maximum cell surface binding at 6 h after injection for Db-IR700 and 24 h after injection for Mb-IR700 and IgG-IR700 as well as 24 h after the peak uptake times. RESULTS:Photoimmunotherapy with the same molar concentration of PSMA-Db-IR700, PSMA-Mb-IR700, and PSMA-IgG-IR700 conjugate showed similar therapeutic effects in vitro and in vivo on PSMA-positive PC3 tumor xenografts in cytotoxicity and survival curves (P > 0.05). CONCLUSION:The use of PSMA-Db-IR700 conjugate results in the shortest time interval between injection and NIR exposure without compromising therapeutic effects of photoimmunotherapy.

PROVIDER: S-EPMC6484861 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5581714 | BioStudies
1000-01-01 | S-EPMC3502522 | BioStudies
2018-01-01 | S-EPMC5922375 | BioStudies
2019-01-01 | S-EPMC7413076 | BioStudies
2018-01-01 | S-EPMC6276043 | BioStudies
2016-01-01 | S-EPMC5029632 | BioStudies
2017-01-01 | S-EPMC5341755 | BioStudies
2020-01-01 | S-EPMC6992936 | BioStudies
1000-01-01 | S-EPMC4924703 | BioStudies
2014-01-01 | S-EPMC4004687 | BioStudies